Log In
Print this Print this

Pulmozyme, dornase alfa

  Manage Alerts
Collapse Summary General Information
Company Genentech Inc.
DescriptionRecombinant deoxyribonuclease (DNase) for inhalation
Molecular Target DNA
Mechanism of Action 
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentMarketed
Standard IndicationCystic fibrosis (CF)
Indication DetailsImprove pulmonary function in patients with cystic fibrosis; Treat advanced cystic fibrosis (CF); Treat cystic fibrosis (CF); Treat mild to moderate cystic fibrosis (CF)
Regulatory Designation

Canada - Orphan Drug (Improve pulmonary function in patients with cystic fibrosis)


Chugai Pharmaceutical Co. Ltd.; Roche

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today